Neuraxis, INC (NRXS) stock
NRXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
$4.87+0.26 (+5.64%)
Close on Nov 18, 2026Market cap $61.16MP/E –Yield –
Neuraxis total assets
Total assets on the balance sheet at the end of each period.
Neuraxis's total assets was $10.00M at Jun 30, 2026. For fiscal 2025 it was $6.40M, up 34.6% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.40M | +34.6% |
| FY2024 | Dec 31, 2024 | $4.76M | +833.8% |
| FY2023 | Dec 31, 2023 | $509.50K | -65.6% |
| FY2022 | Dec 31, 2022 | $1.48M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $10.00M | +41.0% |
| Q1 FY2026 | Mar 31, 2026 | $8.75M | +188.7% |
| Q4 FY2025 | Dec 31, 2025 | $6.40M | +34.6% |
| Q3 FY2025 | Sep 30, 2025 | $5.78M | +405.2% |
| Q2 FY2025 | Jun 30, 2025 | $7.09M | +169.2% |
| Q1 FY2025 | Mar 31, 2025 | $3.03M | +220.4% |
| Q4 FY2024 | Dec 31, 2024 | $4.76M | +833.8% |
| Q3 FY2024 | Sep 30, 2024 | $1.14M | -7.5% |
| Q2 FY2024 | Jun 30, 2024 | $2.63M | +71.0% |
| Q1 FY2024 | Mar 31, 2024 | $945.73K | -36.1% |
| Q4 FY2023 | Dec 31, 2023 | $509.50K | – |
| Q3 FY2023 | Sep 30, 2023 | $1.24M | – |
| Q2 FY2023 | Jun 30, 2023 | $1.54M | – |
| Q4 FY2022 | Dec 31, 2022 | $1.48M | – |
See a number that looks wrong?